M. Stepanova

Clinical and morphological features of breast tumors with PIK3CA mutations in Russian patients: Observational study

A. M. Degtyarev, R. Zukov, A. Vasilevskaya, 2022, Journal of Modern Oncology.

Russian multicenter experience of using talazoparib in the treatment of patients with BRCA-associated metastatic breast cancer

E. Imyanitov, F. Moiseenko, L. Bolotina, 2020, Meditsinskiy sovet = Medical Council.

Monitoring of the presence of EGFR-mutated DNA during EGFR-targeted therapy may assist in the prediction of treatment outcome.

E. Imyanitov, E. Kuligina, V. Moiseyenko, 2022, Cancer treatment and research communications.

Personalized therapy in solid tumors: results of a retrospective multicentre study of the clinical applicability of the FoundationOne® Medicine Test

M. Ivanov, A. Zhabina, N. Volkov, 2022, Pelvic Surgery and Oncology.

Factors affecting the efficacy of gemcitabine and nab-paclitaxel (paclitaxel + albumin) combination in the Russian patient population: results of a multicenter retrospective study

F. Moiseenko, O. Kit, D. Nosov, 2019, Medical Council.